Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
Location: United States, California, Redwood City
Employees: 51-200
Total raised: $292M
Investors 7
Funding Rounds 4
| Date | Series | Amount | Investors |
| 19.09.2022 | - | $150M | - |
| 13.12.2017 | Series B | $100M | - |
| 30.09.2014 | - | $10M | - |
| 17.12.2012 | Series A | $32M | - |
Mentions in press and media 8
| Date | Title | Description |
| 19.09.2022 | Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock | - |
| 13.12.2017 | Allergy, inflammation player Allakos reels in $100M series B W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Five years after bagging a modest $30 million in series A financing, Allakos has picked up a hefty $100 million from the likes of New Enterprise Associates, Partner Fund Management and Roche Ventures. Sponsored by Agilent Technologies How w... |
| 13.12.2017 | Allakos Secures $100 Million In Series B Financing | - |
| 13.12.2017 | Allergy, inflammation player Allakos reels in $100M series B | Five years after bagging a modest $30 million in series A financing, Allakos has picked up a hefty $100 million from the likes of New Enterprise Associates, Partner Fund Management and Roche Ventures. The funds will advance San Carlos, Cali... |
| 30.09.2014 | Allakos Raises $10M in Funding | Allakos, a San Francisco Bay Area-based biotechnology company, raised an additional $10m in funding. Backers included current investors Novo Ventures, Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. The company, which ... |
| 30.09.2014 | Allakos Raises Additional $10M | SAN CARLOS, CA, Allakos Inc. announced today that it has secured an additional $10 million investment from current investors. >> Click here for more funding data on Allakos >> To export Allakos funding data to PDF and Excel,... |
| 17.12.2012 | Allakos Grabs $32M Series A | SAN MATEO, CA, Allakos announced today that it has completed a $32 million Series A preferred stock financing led by Novo Ventures. >> Click here for more funding data on Allakos >> To export Allakos funding data to PDF and ... |
| 17.12.2012 | Allakos Completes $32M Series A Financing | Allakos Inc., a San Francisco Bay Area-based biotechnology company, has completed a $32m Series A financing. The round was led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. In... |